Alginic acid / aluminum hydroxide / magnesium trisilicate Pregnancy and Breastfeeding Warnings

Brand names: Acid Gone Antacid, Alenic Alka Tablet, Gaviscon-2, Genaton Chewable

Alginic acid / aluminum hydroxide / magnesium trisilicate Pregnancy Warnings

Magnesium trisilicate, aluminum hydroxide and alginic acid have not been formally assigned to a pregnancy category by the FDA. There are no controlled data in human pregnancy. Other magnesium salts (such as magnesium sulfate) have been used extensively during pregnancy in large doses with no reports of congenital defects. Magnesium trisilicate, aluminum hydroxide and alginic acid should only be given in pregnancy when benefit outweighs risk.

In a review of 229,101 deliveries to Michigan Medicaid patients, 351 first-trimester exposures to aluminum hydroxide were recorded and 996 exposures any time during pregnancy. A total of 14 birth defects were reported with first trimester exposure (15 expected) and included (observed/expected) 5/4 cardiovascular defects, 2/0.5 oral clefts, 1 polydactyly, and 1 hypospadias.

Data are not available for magnesium trisilicate. However, 341 first-trimester exposures to magnesium hydroxide were recorded as well as 974 exposures any time during pregnancy. A total of 14 birth defects were reported with first trimester exposure (14 expected) and included (observed/expected) 5/3 cardiovascular defects, 2/0.8 polydactyly, and one hypospadias. These data do not support an association between aluminum hydroxide or magnesium hydroxide ingestion and adverse fetal outcome. (written communication, Franz Rosa, MD, Food and Drug Administration, 1994)

See references

Alginic acid / aluminum hydroxide / magnesium trisilicate Breastfeeding Warnings

There are no data on the excretion of alginic acid, aluminum hydroxide, or magnesium trisilicate into human milk.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer